STC PR
SEOUL, South Korea, Feb. 29, 2016 /PRNewswire/ — STC-Stem Cell Treatment & Research Institute (“STRI” or “the Company”) Chairman Kye-ho Lee announced..
temp post
STRI and Fraunhofer kicks off with a pilot study at Halle Germany, using nEPS(newly Elicited Pluripotent Stem cells without side effects by natural compound) to treat Alzheimer’s Study. STRI and Fraunhofer kicks off with a pilot study at Halle…
temp post
STRI and Fraunhofer kicks off with a pilot study at Halle Germany, using nEPS(newly Elicited Pluripotent Stem cells without side effects by natural compound) to treat Alzheimer’s Study. STRI and Fraunhofer kicks off with a pilot study at Halle…
Pluripotent Stem Cell, the New Growth Engine for the Next Generation
Japan, the United States, and Europe are devoting their efforts to stem cell research… The newly elicited pluripotent stem cell without side effects invented by STRI has begun clinical trials.
STC-Stem Cell Treatment & Research Institute Registers Local Patent for Method to Mass…
The patented technology uses latest cell differentiation and cultivation technology, along with low molecular weight compound extracted from a natural compound.
Race for stem cell research begins in Japan, U.S., and European countries STRI from South Korea
Over a decade have passed since Professor Hwang Woo-suk’s famous stem cell scandal involving a forged paper created a nationwide uproar. The Korean society was filled with distrust…
STRI (STC Stem Cell Treatment & Research Institute) registers local patent for method to…
The patented technology uses latest cell differentiation and cultivation technology, along with low molecular weight compound extracted from a natural compound.